Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Convertible Debt (2020 - 2025)

Historic Convertible Debt for Collegium Pharmaceutical (COLL) over the last 6 years, with Q3 2025 value amounting to $238.0 million.

  • Collegium Pharmaceutical's Convertible Debt rose 43.86% to $238.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $238.0 million, marking a year-over-year increase of 43.86%. This contributed to the annual value of $237.2 million for FY2024, which is 951.95% down from last year.
  • Per Collegium Pharmaceutical's latest filing, its Convertible Debt stood at $238.0 million for Q3 2025, which was up 43.86% from $237.7 million recorded in Q2 2025.
  • Over the past 5 years, Collegium Pharmaceutical's Convertible Debt peaked at $262.4 million during Q1 2024, and registered a low of $26.4 million during Q1 2022.
  • Over the past 5 years, Collegium Pharmaceutical's median Convertible Debt value was $236.9 million (recorded in 2024), while the average stood at $196.8 million.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Convertible Debt tumbled by 8108.21% in 2022, and later surged by 89135.48% in 2023.
  • Over the past 5 years, Collegium Pharmaceutical's Convertible Debt (Quarter) stood at $140.0 million in 2021, then grew by 0.65% to $140.9 million in 2022, then soared by 86.07% to $262.1 million in 2023, then fell by 9.52% to $237.2 million in 2024, then increased by 0.33% to $238.0 million in 2025.
  • Its Convertible Debt stands at $238.0 million for Q3 2025, versus $237.7 million for Q2 2025 and $237.4 million for Q1 2025.